Multicenter Phase I Study of Repeated Intratumoral Delivery of Adenoviral p53 in Patients With Advanced Non–Small-Cell Lung Cancer EGFR exon 19 and 21 mutation status was determined in 265 tumor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results